Friday ruling came after FTC and seven states brought a case against Shkreli, nicknamed the ‘Pharma Bro’
Martin Shkreli, the pharmaceutical entrepreneur vilified for astronomically hiking the price of a life-saving drug, has been barred for life from the pharmaceutical industry and fined $64.6m by a US court.
The Friday ruling came after the Federal Trade Commission (FTC) and seven states brought a case against Shkreli, nicknamed the “Pharma Bro” for his sometimes outrageous behavior.
